Apyx Medical Corporation (APYX)

Apyx Medical Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Year	2023	2022	2021	2020	2019
Cash & Equivalents	43.65	10.19	30.87	41.92	58.81
Cash & Cash Equivalents	43.65	10.19	30.87	41.92	58.81
Cash Growth	328.30%	-66.98%	-26.35%	-28.73%	-24.93%
Receivables	14.02	10.7	13.52	9.67	9.22
Inventory	9.92	11.8	6.78	4.05	5.07
Other Current Assets	2.76	10.28	9.57	10.45	3.63
Total Current Assets	70.36	42.97	60.74	66.09	76.73
Property, Plant & Equipment	7.15	7.59	6.87	7.22	7.62
Other Long-Term Assets	1.73	1.22	1.11	0.81	0.39
Total Long-Term Assets	8.88	8.8	7.98	8.02	8.01
Total Assets	79.24	51.78	68.72	74.11	84.75
Accounts Payable	2.71	2.67	2.63	1.51	2.44
Deferred Revenue	1.25	1.41	1.32	0.62	0.41
Current Debt	0.37	0.25	0.29	0.36	0.48
Other Current Liabilities	8.42	7.52	8.96	6.66	8.99
Total Current Liabilities	12.74	11.85	13.21	9.15	12.31
Long-Term Debt	38.13	0.54	0.02	0.31	0.66
Other Long-Term Liabilities	1.44	1.59	1.49	0.79	0.52
Total Long-Term Liabilities	39.58	2.13	1.51	1.1	1.18
Total Liabilities	52.32	13.98	14.71	10.25	13.49
Total Debt	38.5	0.8	0.31	0.68	1.13
Debt Growth	4736.81%	160.98%	-54.88%	-40.34%	709.29%
Retained Earnings	-54.45	-35.74	-12.55	2.62	14.52
Shareholders' Equity	26.7	37.58	53.7	63.72	71.26
Net Cash / Debt	5.15	9.4	30.57	41.24	57.68
Net Cash / Debt Growth	-45.18%	-69.26%	-25.88%	-28.50%	-26.25%
Net Cash Per Share	0.15	0.27	0.89	1.21	1.69
Working Capital	57.62	31.12	47.53	56.94	64.42
Book Value Per Share	0.77	1.09	1.56	1.86	2.09

Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).